PS1401 PATIENT REPORTED EXPERIENCE FROM PART 2 OF THE FIRST TIME IN HUMAN STUDY OF THE BCMA ANTIBODY DRUG CONJUGATE GSK2857916 FOR ADVANCED RELAPSED REFRACTORY MULTIPLE MYELOMA (DREAMM‐1)
Popat, R., Opalinska, J.B., Eliason, L., Wilson, J., Felber, G., Ackert, J., Correll, J., Martin, M.L., Bruno, A.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article
PS1372 B‐CELL MATURATION ANTIGEN ANTIBODY‐DRUG CONJUGATE (ADC), GSK2857916, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): FINAL SAFETY, EFFICACY AND PHARMACOKINETIC (PK) ANALYSES FROM A PHASE I STUDY
Popat, R., Lendvai, N., Trudel, S., Voorhees, P.M., Reeves, B., Libby, E.N., Richardson, P.G., Jr, L.D. Anderson, Sutherland, H.J., Yong, K., Hoos, A., Gorczyca, M.M., He, Z., Jewell, R.C., Dettman, E.J., Rigat, F., Gupta, I., Bragulat, V., Opalinska, J.B., Cohen, A.D.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article